切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2016, Vol. 10 ›› Issue (03) : 274 -279. doi: 10.3877/cma.j.issn.1674-1358.2016.03.005

临床论著

神经梅毒强化驱梅治疗疗效预测因素的回顾性研究
陈勇1, 张玲2, 詹永婧3, 段毓姣4, 徐艳利4, 蒋荣猛4, 李兴旺4,()   
  1. 1. 100015 北京,首都医科大学附属北京地坛医院感染病科国家临床重点专科;075000 张家口市,河北北方学院附属第一医院感染科
    2. 100015 北京,北京大学地坛医院教学医院感染病科国家临床重点专科
    3. 100053 北京,首都医科大学宣武医院感染科
    4. 100015 北京,首都医科大学附属北京地坛医院感染病科国家临床重点专科
  • 出版日期:2016-06-15
  • 通信作者: 李兴旺
  • 基金资助:
    国家科技重大专项项目(No. 2012ZX10005010)

Retrospective study on the predictive factors of curative effect in intensive anti-syphilis therapy for neurosyphilis

Yong Chen1, Ling Zhang2, Yongjing Zhan3, Yujiao Duan4, Yanli Xu4, Rongmeng Jiang4, Xingwang Li4,()   

  1. 1. The National Clinical Key Department of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China; Department of Infectious Diseases, the First Affiliated Hospital of Hebei North University, Zhangjiakou 075000, China
    2. Department of Infectious Diseases, Beijing Ditan Hospital, Peking University Teaching Hospital, Beijing 100015, China
    3. Department of Infectious Diseases, Xuanwu Hospital of Capital Medical University, Beijing 100053, China
    4. The National Clinical Key Department of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
  • Published:2016-06-15
  • Corresponding author: Xingwang Li
引用本文:

陈勇, 张玲, 詹永婧, 段毓姣, 徐艳利, 蒋荣猛, 李兴旺. 神经梅毒强化驱梅治疗疗效预测因素的回顾性研究[J]. 中华实验和临床感染病杂志(电子版), 2016, 10(03): 274-279.

Yong Chen, Ling Zhang, Yongjing Zhan, Yujiao Duan, Yanli Xu, Rongmeng Jiang, Xingwang Li. Retrospective study on the predictive factors of curative effect in intensive anti-syphilis therapy for neurosyphilis[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2016, 10(03): 274-279.

目的

探讨神经梅毒强化驱梅治疗疗效的预测因素。

方法

回顾性分析67例HIV阴性实验室确诊的神经梅毒患者的临床资料,采用Logisitic回归分析方法,分析性别、年龄、临床分型、既往驱梅治疗史、强化驱梅前血清梅毒快速血清反应试验(serum-RPR)滴度、脑脊液白细胞(CSF-WBC)计数、脑脊液蛋白(CSF-PRO)水平、脑脊液RPR(CSF-RPR)滴度等对驱梅治疗后6~12个月血清RPR滴度正常化的影响。

结果

入选的67例患者,平均年龄为(47.52 ± 11.29)岁,男︰女= 3.19︰1。在多因素Logistic回归模型中,驱梅前serum-RPR滴度、CSF-WBC计数与驱梅治疗后6~12个月serum-RPR滴度正常化呈正相关(P均< 0.05;OR = 2.449,95%CI:1.390~4.312;OR = 1.017,95%CI:1.000~1.034),而驱梅前CSF-RPR滴度与驱梅治疗后6~12个月血清RPR滴度正常化呈负相关(P均< 0.05,OR = 0.510,95%CI:0.294~0.887)。在单因素Logisitic回归分析中,强化驱梅前serum-RPR滴度和CSF-WBC计数是驱梅治疗后6~12个月serum-RPR滴度正常化的独立预测因素(P均< 0.05;OR = 1.653,95%CI:1.157~2.361;OR = 1.016,95%CI:1.000~1.032)。

结论

强化驱梅前serum-RPR滴度水平及CSF-WBC计数对强化驱梅的有效性具有一定的预测作用。而脑脊液RPR滴度,是强化驱梅治疗效果较差的预测因素。宿主的免疫状态对神经梅毒的疗效和转归可能有重要作用。

Objective

To investigate the predictive factors of curative effect in intensive anti-syphilis therapy for neurosyphilis.

Methods

The clinical data of 67 cases with HIV negative neurosyphilis confirmed by lab test were analyzed, retrospectively. The probably predicative factors including the age, gender, clinical categories, history of anti-syphilis treatment, serum rapid plasma regain test (serum-RPR) titer, cerebrospinal fluid (CSF) RPR titer, CSF white blood cell (WBC) count, and CSF protein level before intensive anti-syphilis therapy were measured by Logisitic regression analysis to predict the normalization of serum RPR during 6-12 month after the therapy.

Results

The average age of 67 cases which met inclusion criteria was (47.52 ± 11.29) years old. The ratio of male︰female was 3.19︰1. In the multivariate Logistic model, the serum-RPR titer, the CSF-RPR titer, and the CSF-WBC count before intensive anti-syphilis therapy were meaningful predictive factors for the normalization of serum RPR during 6-12 month after the therapy. The serum-RPR titer and the CSF-WBC count before intensive therapy were positively predictive factors for the normalization of serum RPR during 6-12 month after the therapy (P < 0.05; OR = 2.449, 95%CI: 1.390-4.312; OR = 1.017, 95%CI: 1.000-1.034), but the CSF-RPR titer was a negative predictive factor (P < 0.05; OR = 0.510, 95%CI: 0.294-0.887). Furthermore, in the univariate Logistic analysis, the serum-RPR titer and the CSF-WBC count before the therapy were independently predictive factors for the normalization of serum RPR during 6-12 month after the therapy (P < 0.05, OR = 1.653, 95%CI: 1.157-2.361; OR = 1.016, 95%CI: 1.000-1.032).

Conclusions

The serum RPR titer, and the CSF-WBC count before intensive therapy were positively predictive factors for curative effect in neurosyphilis, however, the CSF RPR titer may be a negative predictive factor for that. Moreover, the immunity mechanism of the host may play an important role in the curative effect and outcome of neurosyphilis.

表1 神经梅毒治疗效果预测因素赋值表
表2 采用进入策略筛选解释变量的结果
表3 多因素Logistic回归分析结果
表4 预测因素的单因素Logisitic回归分析结果
1
龚向东,岳晓丽,滕菲, 等. 2000-2013年中国梅毒流行特征与趋势分析[J]. 中华皮肤科杂志,2014,47(5):310-315.
2
Lukehart SA, Hook EW 3rd, Baker-Zander SA, et al. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment[J]. Ann Intern Med,1988,109(11):855-862.
3
Workowski KA, Berman S. Sexually transmitted diseases treatment guidelines, 2010[J]. MMWR Recomm Rep,2010,59(RR-12):1-110.
4
中国疾病预防控制中心性病控制中心,中华医学会皮肤性病学分会性病学组,中国医师协会皮肤科医师分会性病亚专业委员会. 梅毒,淋病,生殖器疱疹,生殖道沙眼衣原体感染诊疗指南(2014)[J]. 中华皮肤科杂志,2014,47(5):365-372.
5
Dennis L, Kasper EB, Anthony Fauci SH, et al. Harrison’s principles of internal medicine 16th edition[M]. McGraw-Hill Medical Publishing Divsion. 2004:977-985.
6
Marra CM, Maxwell CL, Tantalo LC, et al. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis[J]. Clin Infect Dis,2008,47(7):893-899.
7
Patton ME, Su JR, Nelson R, et al. Primary and secondary syphilis--United States, 2005-2013[J]. MMWR Morb Mortal Wkly Rep,2014,63(18):402-406.
8
Read P, Fairley CK, Chow EP. Increasing trends of syphilis among men who have sex with men in high income countries[J]. Sex Health,2015,12(2):155-163.
9
Ghanem KG. Neurosyphilis: a historical perspective and review[J]. CNS Neurosci Ther,2010,16(5):e157-e168.
10
Clement ME, Okeke NL, Hicks CB. Treatment of syphilis: a systematic review[J]. JAMA,2014,312(18):1905-1917.
11
Ghanem KG, Workowski KA. Management of adult syphilis[J]. Clin Infect Dis,2011,53(Suppl 3):S110-S128.
12
Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features[J]. J Infect Dis,2004,189(3):369-376.
13
Wang C, Zhu L, Gao Z, et al. Increased interleukin-17 in peripheral blood and cerebrospinal fluid of neurosyphilis patients[J]. PLoS Negl Trop Dis,2014,8(7):e3004.
14
Clark EG, Danbolt N. The Oslo study of the natural history of untreated syphilis; an epidemiologic investigation based on a restudy of the Boeck-Bruusgaard material: a review and appraisal[J]. J Chronic Dis,1955,2(3):311-344.
15
Leader BT, Godornes C, VanVoorhis WC, et al. CD4+ lymphocytes and gamma interferon predominate in local immune responses in early experimental syphilis[J]. Infect Immun,2007,75(6):3021-3026.
16
Marra CM, Castro CD, Kuller L, et al. Mechanisms of clearance of Treponema pallidum from the CSF in a nonhuman primate model[J]. Neurology,1998,51(4):957-961.
17
Li K, Wang C, Lu H, et al. Regulatory T cells in peripheral blood and cerebrospinal fluid of syphilis patients with and without neurological involvement[J]. PLoS Negl Trop Dis,2013,7(11):e2528.
18
Pastuszczak M, Jakiela B, Wielowieyska-Szybinska D, et al. Elevated cerebrospinal fluid interleukin-17A and interferon-gamma levels in early asymptomatic neurosyphilis[J]. Sex Transm Dis,2013,40(10):808-812.
19
Stary G, Klein I, Bruggen MC, et al. Host defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-/IL-17-producing CD8+ T cells[J]. Am J Pathol,2010,177(5):2421-2432.
20
Carlson JA, Dabiri G, Cribier B, et al. The immunopathobiology of syphilis: the manifestations and course of syphilis are determined by the level of delayed-type hypersensitivity[J]. Am J Dermatopathol,2011,33(5):433-460.
21
Curtis MM, Way SS. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens[J]. Immunology,2009,126(2):177-185.
[1] 沈立平, 龙驭云, 杨月华, 张敏, 许阳, 赵亚丽, 李静, 张昀, 江世文, 孙志明. 不同避孕方式对女性再次受孕的影响因素分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(01): 107-112.
[2] 李涛, 杨义, 冯光, 郝岱峰. 北京市某三甲医院创面修复专科病区5年间糖尿病足住院病例回顾性分析[J]. 中华损伤与修复杂志(电子版), 2022, 17(05): 405-410.
[3] 苗敏, 杨洪玲, 刘洋, 庞琳. 接种与未接种麻疹疫苗儿童麻疹的临床特征[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(02): 110-116.
[4] 师璐, 黄宇明, 寇程, 秦开宇, 吴雅丽, 马小扬, 许东梅. 夫妻共同感染梅毒螺旋体临床表型及实验室指标差异[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(05): 328-336.
[5] 许东梅, 马小扬, 黄宇明. 神经梅毒诊疗现状及进展[J]. 中华实验和临床感染病杂志(电子版), 2022, 16(05): 300-306.
[6] 杨董超, 宋致成, 宋衡, 杨建军, 顾岩. 腹壁肿瘤扩大切除一期桥接修复腹壁缺损的回顾性研究[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(04): 380-384.
[7] 张梓榕, 陈富强, 郭迎凤, 周昊, 韩硕, 陈杰. 两种补片在嵌顿性腹股沟疝中的疗效[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(01): 24-27.
[8] 谢海亮, 郑国富, 郭仪, 刘云强, 刘小春, 谢元才. 急诊和择期股疝临床特点及其修补后早期临床效果的回顾性队列研究[J]. 中华疝和腹壁外科杂志(电子版), 2022, 16(06): 668-671.
[9] 李华娟, 唐英俊, 王赛妮, 徐旺, 林玲, 李羲, 黄华萍. 肺结节临床与CT影像学特征分析及良恶性预测模型构建[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 318-323.
[10] 胡建生, 周佐霖, 孙林梅, 马腾辉. 不同诊断分型的慢性放射性直肠损伤临床治疗转归:85例回顾性分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 466-472.
[11] 徐峰, 张英皓, 谢娜, 高谦. 肩部疼痛相关病理和危险因素的回顾性研究[J]. 中华肩肘外科电子杂志, 2022, 10(04): 327-337.
[12] 李俊锋, 黄钊, 程建文, 冯启明, 廖亮, 许国杰, 程洪, 郑铁军, 陈丁泉, 凌赫, 吕炳泉, 覃家港, 覃永念, 许运德, 覃娴静, 苏伟, 赵劲民. 广西壮族自治区急性骨筋膜室综合征的流行病学特征分析[J]. 中华老年骨科与康复电子杂志, 2022, 08(04): 243-249.
[13] 丁玉菊, 刘照勇, 张波. 获得性脑损伤患者成功拔除气管套管的预测因素研究[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(02): 108-112.
[14] 翁梓珑, 朱丽, 林大卫, 潘文志, 周达新, 葛均波. 国产经导管瓣膜系统治疗重度主动脉瓣狭窄长期预后及其预测因素分析[J]. 中华心脏与心律电子杂志, 2023, 11(02): 114-119.
[15] 王宇梅, 刘猛. 脑梗死后恶性脑水肿预测因素的研究进展[J]. 中华脑血管病杂志(电子版), 2023, 17(02): 163-166.
阅读次数
全文


摘要